Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christian Dittrich, MD
Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital
Study Chair - Maurizio D'Incalci, MD
Mario Negri Institute for Pharmacological Research
Study Chair - Robert E. Coleman, MD, FRCP
Cancer Research Centre at Weston Park Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ludwig Boltzmann - Institute for Applied Cancer Research
Vienna, Austria
- Institut Bergonie
Bordeaux, France
- Centre Jean Perrin
Clermont-Ferrand, France
- Institut Curie - Section Medicale
Paris, France
- Centre Henri Becquerel
Rouen, France
- University of Ioannina
Ioannina, Greece
- Rabin Medical Center - Beilinson Campus
Petah Tikva, Israel
- Mario Negri Institute for Pharmacological Research
Milano (Milan), Italy
- Istituti Fisioterapici Ospitalieri - Roma
Rome, Italy
- Academisch Ziekenhuis Groningen
Groningen, Netherlands
- University Medical Center Nijmegen
Nijmegen, Netherlands
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Clinique de Genolier
Genolier, Switzerland
- Royal Marsden Nhs Trust
London, England, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2000
- Primary completion
- 31 Jul 2002
- Completion
- —
- Last update posted
- 18 Jul 2012
- Registered enrollment
- 116
- Registry id
- NCT00005980
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.